Search research articles
Contact Us
Filters
Showing results (41-50 of 168) with videos related to
Page
of 17
Sort By:
Clinical Colorectal Cancer
|
October 6, 2010
Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?
Joseph Ciccolini, Eva Gross, Laetitia Dahan, et al.
European Journal of Clinical Pharmacology
|
June 22, 2010
Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism
Cédric Mercier, Laetitia Dahan, L'houcine Ouafik, et al.
Plos One
|
September 30, 2022
Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic
Anne Rodallec, Cristina Vaghi, Joseph Ciccolini, et al.
Nature Reviews. Clinical Oncology
|
November 25, 2015
Computational oncology--mathematical modelling of drug regimens for precision medicine
Dominique Barbolosi, Joseph Ciccolini, Bruno Lacarelle, et al.
Fundamental & Clinical Pharmacology
|
July 7, 2025
DPD Ultra-Rapid Metabolizer Status and Efficacy of 5-Fluorouracil Treatment: A Real-World Study
Govind Kallee, Gérard Milano, Florence Duffaud, et al.
British Journal of Clinical Pharmacology
|
March 14, 2019
Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?
Godefridus J Peters, Elisa Giovannetti, Richard J Honeywell, et al.
Pharmaceutics
|
August 16, 2020
Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Guillaume Sicard, Frédéric Fina, Raphaelle Fanciullino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2015
Ang1 and Tie2 are predictive biomarkers for bevacizumab-letter
Joseph Ciccolini, Cindy Serdjebi, Dominique Barbolosi, et al.
Current Drug Targets
|
November 15, 2014
Trastuzumab-induced cardiotoxicity: is it a personalized risk?
Gerard A Milano, Emilie Serres, Jean-Marc Ferrero, et al.
Planta Medica
|
July 31, 2008
Cytotoxic effects of haplamine and its major metabolites on human cancer cell lines
Sompheary Ea, Sarah Giacometti, Joseph Ciccolini, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 168) with videos related to
Sort By:
Page
of 17
Clinical Colorectal Cancer
|
October 6, 2010
Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?
Joseph Ciccolini, Eva Gross, Laetitia Dahan, et al.
European Journal of Clinical Pharmacology
|
June 22, 2010
Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism
Cédric Mercier, Laetitia Dahan, L'houcine Ouafik, et al.
Plos One
|
September 30, 2022
Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic
Anne Rodallec, Cristina Vaghi, Joseph Ciccolini, et al.
Nature Reviews. Clinical Oncology
|
November 25, 2015
Computational oncology--mathematical modelling of drug regimens for precision medicine
Dominique Barbolosi, Joseph Ciccolini, Bruno Lacarelle, et al.
Fundamental & Clinical Pharmacology
|
July 7, 2025
DPD Ultra-Rapid Metabolizer Status and Efficacy of 5-Fluorouracil Treatment: A Real-World Study
Govind Kallee, Gérard Milano, Florence Duffaud, et al.
British Journal of Clinical Pharmacology
|
March 14, 2019
Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?
Godefridus J Peters, Elisa Giovannetti, Richard J Honeywell, et al.
Pharmaceutics
|
August 16, 2020
Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Guillaume Sicard, Frédéric Fina, Raphaelle Fanciullino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2015
Ang1 and Tie2 are predictive biomarkers for bevacizumab-letter
Joseph Ciccolini, Cindy Serdjebi, Dominique Barbolosi, et al.
Current Drug Targets
|
November 15, 2014
Trastuzumab-induced cardiotoxicity: is it a personalized risk?
Gerard A Milano, Emilie Serres, Jean-Marc Ferrero, et al.
Planta Medica
|
July 31, 2008
Cytotoxic effects of haplamine and its major metabolites on human cancer cell lines
Sompheary Ea, Sarah Giacometti, Joseph Ciccolini, et al.
Page
of 17